Target Company Profile: Genentech

Genentech, Inc. is a biotechnology company that uses human genetic information to discover, develop, manufacture and market human pharmaceuticals for significant unmet medical needs.Genetech manufactures and markets eight products

Genentech has developed seven products, co-developed one product and manufactures and markets eight of its products :Herceptin, Rituxan, monoclonal antibody, Activase, Protropin, Nutropin, Nutropin AQ, Pulmozyme, and Actimmune.

As part of the Agreement, the Company receives royalties on sales of its products in Canada, on sales of Pulmozyme outside of the U.S. and on sales of rituximab outside of the U.S. (excluding Japan) from HLR. The Company receives royalties on sales of two of its products, growth hormone and t-PA, outside of the U.S. and Canada through other licensees.

Learn more here: http://www.genentech.com